141 related articles for article (PubMed ID: 37931279)
1. Predictors of disease recurrence in high-risk non-metastatic renal cell carcinoma patients post-surgical resection A single-center, retrospective study.
Taneja S; Bonert M; Hoogenes J; Matsumoto K; Shayegan B; Matsumoto ED; Lambe S; Piercey K; Kapoor A
Can Urol Assoc J; 2024 Mar; 18(3):E53-E58. PubMed ID: 37931279
[TBL] [Abstract][Full Text] [Related]
2. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.
Shah PH; Moreira DM; Okhunov Z; Patel VR; Chopra S; Razmaria AA; Alom M; George AK; Yaskiv O; Schwartz MJ; Desai M; Vira MA; Richstone L; Landman J; Shalhav AL; Gill I; Kavoussi LR
J Urol; 2016 Aug; 196(2):327-34. PubMed ID: 26907508
[TBL] [Abstract][Full Text] [Related]
3. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
Kryvenko ON
Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors of patients with T3N0M0 renal cell carcinoma: a single-center retrospective study of 182 patients].
Peng D; Li XS; Zhang CJ; Yang KW; Tang Q; Zhang L; Yu XT; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):806-811. PubMed ID: 27752160
[TBL] [Abstract][Full Text] [Related]
6. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
7. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
9. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for disease recurrence in patients with locally advanced renal cell carcinoma treated with curative surgery.
Chang TW; Cheng WM; Fan YH; Lin CC; Lin TP; Yi-Hsiu Huang E; Chung HJ; Huang WJS; Weng SH
J Chin Med Assoc; 2021 Apr; 84(4):405-409. PubMed ID: 33595988
[TBL] [Abstract][Full Text] [Related]
11. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
12. Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma.
Galtung KF; Lauritzen PM; Baco E; Berg RE; Naas AM; Rud E
Anticancer Res; 2022 Jun; 42(6):2967-2975. PubMed ID: 35641263
[TBL] [Abstract][Full Text] [Related]
13. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma.
Neves JB; Vanaclocha Saiz L; Abu-Ghanem Y; Marchetti M; Tran-Dang MA; El-Sheikh S; Barod R; Beisland C; Capitanio U; Cullen D; Klatte T; Ljungberg B; Mumtaz F; Patki P; Stewart GD; Dabestani S; Tran MGB; Bex A;
World J Urol; 2021 Oct; 39(10):3823-3831. PubMed ID: 33851271
[TBL] [Abstract][Full Text] [Related]
14. Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus.
Abel EJ; Carrasco A; Karam J; Tamboli P; Delacroix S; Vaporciyan AA; Wood CG
BJU Int; 2014 Nov; 114(5):667-73. PubMed ID: 24128265
[TBL] [Abstract][Full Text] [Related]
15. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
16. Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors.
Mouracade P; Kara O; Maurice MJ; Dagenais J; Malkoc E; Nelson RJ; Kaouk JH
J Urol; 2017 Jun; 197(6):1403-1409. PubMed ID: 27993666
[TBL] [Abstract][Full Text] [Related]
17. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
18. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
Bani-Hani AH; Leibovich BC; Lohse CM; Cheville JC; Zincke H; Blute ML
J Urol; 2005 Feb; 173(2):391-4. PubMed ID: 15643178
[TBL] [Abstract][Full Text] [Related]
19. Local Recurrence After Curative Surgical Treatment of Renal Cell Cancer: A Study of 91 Patients.
Du Y; Grüllich C; Hadaschik B; Hatiboglu G; Hohenfellner M; Pahernik S
Clin Genitourin Cancer; 2016 Aug; 14(4):e379-85. PubMed ID: 26971248
[TBL] [Abstract][Full Text] [Related]
20. [Pathological prognostic indicators in renal cell carcinoma].
Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
